blood pressure,2 yet the 21 mm Hg level is taken as the average for all adults; for a young adult Caucasian this level may therefore be too high, and conversely for an octagenarian it may be too low. The problem is further confounded on translating the results for Caucasians to other populations. For example Japanese adults show a fall in IOP with age,3 again in line with systemic blood pressure. The mean IOP for an elderly Japanese patient is lower than for his Western counterpart, and so is his upper limit ofnormal. There will be a far greater prevalence of low tension glaucoma in Japan if definitions ofnormal based on Western pressure levels rather than Japanese ones are used, and this is the case. Of greater relevance to the urban populations in the United Kingdom is the fact that while West Africans have low IOPs (with large cup/disc ratios) with large numbers of'low tension glaucomas' some of their Caribbean descendants may There have been no detected differences in the topography of the optic disc'6 but the incidence of splinter haemorrhages on the optic disc is higher in normal than in high tension glaucoma.7 8 Comparisons of the visual field have tended to agree that while the visual field defects in normal tension glaucoma may be more likely to show dense defects close to fixation, this is not diagnostic.4 It has been suggested that the uninvolved hemifield is more likely to be 'normal' without evidence of diffuse visual loss in normal tension glaucoma.' 16 This finding has not been confirmed by other studies and seems to have been due to the analysis method used. The nature of the visual field loss would appear the same in normal tension and high tension glaucoma.
Though there is little difference in male:female ratios in patients with high tension glaucoma, the ratio in normal tension glaucoma is 1:2. There are no apparent rheological, haematological, or vascular differences between patients with normal and high tension glaucoma.17 18 Subgroups of normal tension glaucoma Greve The question of pathogenesis is unresolved at the present time, and with this uncertainty comes concern about what treatment, if any, to give.
Management
Treatment for high tension glaucoma is given on the not unreasonable assumption that the high tension is at least partly responsible for the visual field loss and if the tension remains high the condition will progress. Treatment for these eyes is designed to halt, or at least slow, this inevitable progression.
As noted above it can be difficult to distinguish between eyes with an anterior ischaemic optic neuropathy and normal tension glaucoma until they progress. There is no point in treating a non-progressive disease. The first requirement in management, therefore is (a) to rule out 'retrolaminar' causes for the visual loss (remembering that a skull x ray is inadequate for this purpose and that if doubt exists as to the nature of the visual loss the patient should undergo a computed tomographic or magnetic resonance imaging scan), and (b) to have the wherewithal to follow the patient by assessing the optic disc and IOP, but most importantly by monitoring the visual fields.
Early attempts with kinetic perimetry using the Goldmann perimeter identified progression over 2-10 years of follow up in about 40-60% of eyes.'2 28 Progression, when it occurred, often did so in a stepwise fashion (also noted in eyes with high tension glaucoma). 29 The use of computer assisted static perimetry, especially with linear regressioi analysis of individual retinal test locations, allowed the identification of progression more quickly and detected it more often in these eyes.3031 Therefore the patient should be followed with 4-6 monthly computer assisted perimetry and the visual fields analysed by linear regression analysis of each retinal point.
Using this technique it is reasonable to watch the patient without treatment until evidence of progression occurs. At least 12 months of sequential perimetry may be needed for this purpose.
The treatment given to eyes with low tension glaucoma has traditionally been standard glaucoma therapy, medical laser, 32 or surgery. In a recent review of the results of such an approach Gjiessen concluded that neither medical nor laser therapy could be relied upon to produce a significant or worthwhile lowering of IOP. ' [2] [3] [4] [5] years is a comparatively short period of time, and the IOPs achieved, in the low 'teens, may still have been too high. The Glaucoma Foundation is coordinating a multicentre study to answer these questions. Faced with a patient having progressive normal pressure glaucoma it is still justifiable to offer fistulising surgery as an option, at least to one eye. If electing to take this route, consideration should be given to the use of 5-fluorouracil, particularly if the patient is young, black, or has already received long term topical antiglaucoma treatment before.36 37 What options exist other than surgery? Recently attention has been drawn to the above average incidence of migraine and associated peripheral vasospasm in patients with normal tension glaucoma.354' It has been suggested that these eyes may suffer from focal arteriolar constriction in the optic nerve, with subsequent optic atrophy.42 Calcium channel blockers, by causing smooth muscle relaxation, have been put forward as a long term treatment in such cases. 43 The calcium channel blockers in current use, such as nifedipine (Adalat), can cause significant hypotension and could be contraindicated in many of our patients for this reason. 'Second generation' drugs such as lisinopril may prove easier to use. This approach, though of theoretical value, has yet to be shown to delay let alone halt progression of this disease. 
